Exchange: NASDAQ·Updated 07:45 PM EDT
ATAI logo

ATAI AtaiBeckley Inc.

$7.39
$0.05
(0.68%)
Today
Closed $7.39
$0.08
(1.08%)
After Hours
EarningsNov 12
Mkt Cap$2.72B
Vol10.31M

About ATAI

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.
57

Bullish Sentiment

How do you feel about ATAI?

FendersDad
$ATAI I voted no. I've had this stock for several years and couldn't in good conscience vote for this crappy deal. I expect it'll go through anyway so that will be that, but something behind the scenes stinks. I've already picked up a lot more compass pathways and Cybin as I expect they are going up more after this sale goes through.
5
GeorgeJetson17
Sold my $ATAI position in full, which I’ve held since 2022. Sad day, but didn’t want to deal with the tax headaches of the CVRs.
4
BigCatNY
$ATAI I sold my long position at $7.40 🥲 .... keeping the short positions for now. This was a nice ride after 2 years.. could have been great. oh well.
1
nottoday800
$ATAI i sold 75%…. keeping the rest for gold spread the winning between trlv - best in class weed tmc- rare earth approval coming valn - lyme disease approval coming
focafoca99
$ATAI announces a merger with Eli Lilly and Albali Acquisition, making it a Lilly subsidiary pending regulatory clearance.

Advertisement|Remove ads.